Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine in Older Adults Who Received a Primary Vaccination (3 or More Years Earlier) in Study MET49
Clinical trial NCT04142242 · COMPLETED
Trial details
- NCT number
- NCT04142242
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-04
- Primary completion
- 2020-04-01
- Enrollment
- 471
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.